PMID: 6983044Dec 1, 1982Paper

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

Neurology
G Di ChiroA P Wolf

Abstract

Positron emission tomography was used to measure local cerebral glucose utilization by the 1-[18F]fluoro-2-deoxy-D-glucose technique in 23 patients with cerebral gliomas. All 10 high-grade (III and IV) astrocytomas demonstrated a region of high activity with a glucose consumption of 7.4 +/- 3.5 (SD) mg/100 gm per minute. The 13 low-grade (I and II) gliomas had a glucose metabolic rate of 4.0 +/- 1.8 mg/100 gm per minute, with no distinctly visible hot spot. Thus, we found a correlation between rate of glycolysis and malignancy in primary cerebral tumors. Cerebral cortical glucose utilization was often depressed in areas adjacent to or neurally connected to the tumor site, and there was focal irregular delta wave EEG activity in these areas.

Citations

May 7, 1998·Head & Neck·W F McGuirtK R Geisinger
Feb 19, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M von KienlinC Rémy
Jul 1, 1993·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·D G SchuppM Garwood
Jun 1, 1988·Cancer Metastasis Reviews·R A Hawkins, M E Phelps
May 1, 1989·Journal of Neuro-oncology·C M CarapellaA Caputo
Feb 1, 1991·Journal of Neuro-oncology·J M RozentalR J Nickles
Jan 1, 1986·European Journal of Nuclear Medicine·T TsukiyamaT Tsubokawa
Mar 1, 1987·Metabolic Brain Disease·D J LoreckC J Cummins
Jan 1, 1994·Journal of Neuro-oncology·P Vaupel
Jan 1, 1994·Journal of Neuro-oncology·U Roelcke
Jan 1, 1994·Journal of Neuro-oncology·R G Blasberg
Jan 1, 1994·Journal of Neuro-oncology·C FerrareseM J Fulham
Jan 1, 1995·Journal of Neuro-oncology·J MeixensbergerH Reichmann
Aug 1, 1996·European Journal of Nuclear Medicine·H NambaK Sueyoshi
Dec 1, 1996·European Journal of Nuclear Medicine·P RigoJ Foidart-Willems
Nov 1, 1996·European Journal of Nuclear Medicine·E TedeschiM Salvatore
Oct 1, 1996·European Journal of Nuclear Medicine·T KuwertO Schober
Jan 1, 1984·Neurosurgical Review·D G ThomasD J Brooks
Jan 1, 1986·Journal of Neuro-oncology·R G BlasbergJ D Fenstermacher
Jan 1, 1985·Journal of Neuro-oncology·R G BlasbergJ D Fenstermacher
Feb 25, 1998·Metabolic Brain Disease·N Haghighat, D W McCandless
Mar 1, 1996·Metabolic Brain Disease·N Haghighat, D W McCandless
Jul 9, 2003·Annals of Nuclear Medicine·Masayuki SasakiHiroshi Honda
Jun 1, 1997·Medical Oncology·C S Brock, M Bower

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.